Changes in Directors' Responsibilities
First written in FY2018-Q2. . Latest entry: FY2026.
The whole theme swung hardest in 2026: 4 of 26 companies on the "Worse" side.
31 other companies' latest entry also says "Other".
- FY2026Board composition and changes in positionsAnnual report
「As of the filing date, 23 October 2026, the Board of Directors comprises 10 directors, including 4 outside directors.」
Following changes in positions between October 2025 and May 2026, the Board of Directors as of the filing date comprises 10 directors, including 4 outside directors. - FY2024Appointment of an outside director and expansion of the Board of DirectorsAnnual report
「As of the filing date, the Board of Directors consists of 9 directors, including 4 outside directors.」
As of the filing date, the Board of Directors consisted of 9 directors, including 4 outside directors, reflecting the appointment of Hayashi Yukako (林 由佳子) as an outside director. - FY2024-Q3Changes in positions and responsibilitiesAnnual report
「Director Director Head Office Sales Horie Noriko (堀江典子) 16 February 2024」
Effective 16 February 2024, head office sales was added to Horie Noriko's (堀江典子) responsibilities. - FY2023Changes in executive structure and responsibilitiesAnnual report
「October 2023 Appointed as a director responsible for the Administration Division of the Company (incumbent)」
Higashiyama Hirotaka (東山 寛尚) was appointed as a director responsible for the Administration Division, while Kim Yeong-il (金 英一) was also appointed as a director responsible for research and development, among other changes to the executive structure and allocation of responsibilities. - FY2022-Q3Changes in positions and responsibilitiesAnnual report
「Changes in executive positions New position Former position Name Effective date Senior Managing Director Sales Department Development Department Production Control Department Quality Control and Quality Assurance Department Restaurant Business Division Senior Managing Director Sales Department Tokyo Sales Department International Sales Department General Manager, Restaurant Business Division Horie Noriko (堀江 典子) 16 April 2022 Senior Managing Director Mail-Order Business Division Biomedical Department Representative Director and President, ㈱フューチャーラボ Representative Director and President, ㈱メディラボ Senior Managing Director Mail-Order Business Division General Manager, Cosmetics Mail-Order Business Division Representative Director and President, ㈱フューチャーラボ Representative Director and President, ㈱メディラボ Inoue Yasunori (井上 泰範) 16 April 2022 Director Director Biomedical Department Aozasa Masayoshi (青笹 正義) 16 April 2022」
Effective 16 April 2022, the allocation of responsibilities across sales, development, production control, quality control, mail-order operations and biomedical operations, among others, was changed. - FY2021Appointment of Outside DirectorAnnual report
「October 2021 Appointed as a director of the Company (incumbent)」
As an executive change through the filing date, Ueda Taro (上田 太郎) was appointed as an outside director in October 2021. - FY2020-Q3Changes in positions and responsibilitiesAnnual report
「Executive Managing Director Administration Department Executive Managing Director Mail-Order Business Division Biomedical Department Restaurant Business Division Masuda Kazuyuki (益田 和二行) 1 February 2020」
Effective 1 February 2020, the positions and responsibilities of Masuda, Aozasa, Horie and Inoue were changed, and the allocation of responsibilities across administration, mail-order operations, biomedical operations and sales, among others, was revised. - FY2019Changes in executive structure and positionsAnnual report
「October 2019 Appointed as a director of the Company (incumbent)」
As an executive change through the filing date, Inoue Yasunori (井上 泰範) was appointed as a director in October 2019. - FY2019-Q2Changes in positions and responsibilitiesAnnual report
「Senior Managing Director, Mail-Order Business Division; Biomedical Department; Restaurant Business Division」
Effective 1 December 2018, the responsibilities of multiple senior managing directors and directors were changed. - FY2018-Q2First statedAnnual report
「Senior Managing Director, Mail-Order Business Division; General Affairs Department; Corporate Planning」
Effective 1 January 2018, general affairs and corporate planning were added to Masuda Kazuyuki's (益田 和二行) responsibilities, while Aozasa Masayoshi (青笹 正義) became responsible for the Biomedical Department, representing changes in positions and responsibilities.